| Dr Steven Jay Welish, MD | |
|
718 Teaneck Rd, Teaneck, NJ 07666-4245 | |
| (201) 530-7917 | |
| (201) 357-8217 |
| Full Name | Dr Steven Jay Welish |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 38 Years |
| Location | 718 Teaneck Rd, Teaneck, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639147325 | NPI | - | NPPES |
| 4589700 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA05629400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Home Care | Teaneck, NJ | Home health agency |
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Medical Associates Pa | 4284647868 | 182 |
| Holy Name Hospital Ekg Interpretation Group | 5294798849 | 13 |
News Archive
Jamaica has already achieved some U.N. Millennium Development Goal (MDG) targets and is "on track" to attain five more, according to a report that mapped the country's progress toward the MDGs, the Jamaica Observer reports.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
Perrigo Company today announced that it has received tentative approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets (repaglinide tablets).
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
As an embryo develops, different genes are turned on in different cells, to form muscles, neurons and other bodily parts. Inside each cell's nucleus, genetic sequences known as enhancers act like remote controls, switching genes on and off. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, can now see - and predict - exactly when each remote control is itself activated, in a real embryo.
› Verified 2 days ago
| Entity Name | Holy Name Hospital Ekg Interpretation Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699805978 PECOS PAC ID: 5294798849 Enrollment ID: O20041105000062 |
News Archive
Jamaica has already achieved some U.N. Millennium Development Goal (MDG) targets and is "on track" to attain five more, according to a report that mapped the country's progress toward the MDGs, the Jamaica Observer reports.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
Perrigo Company today announced that it has received tentative approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets (repaglinide tablets).
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
As an embryo develops, different genes are turned on in different cells, to form muscles, neurons and other bodily parts. Inside each cell's nucleus, genetic sequences known as enhancers act like remote controls, switching genes on and off. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, can now see - and predict - exactly when each remote control is itself activated, in a real embryo.
› Verified 2 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
Jamaica has already achieved some U.N. Millennium Development Goal (MDG) targets and is "on track" to attain five more, according to a report that mapped the country's progress toward the MDGs, the Jamaica Observer reports.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
Perrigo Company today announced that it has received tentative approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets (repaglinide tablets).
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
As an embryo develops, different genes are turned on in different cells, to form muscles, neurons and other bodily parts. Inside each cell's nucleus, genetic sequences known as enhancers act like remote controls, switching genes on and off. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, can now see - and predict - exactly when each remote control is itself activated, in a real embryo.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Jay Welish, MD 718 Teaneck Rd, Teaneck, NJ 07666-4245 Ph: (201) 530-7917 | Dr Steven Jay Welish, MD 718 Teaneck Rd, Teaneck, NJ 07666-4245 Ph: (201) 530-7917 |
News Archive
Jamaica has already achieved some U.N. Millennium Development Goal (MDG) targets and is "on track" to attain five more, according to a report that mapped the country's progress toward the MDGs, the Jamaica Observer reports.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
Perrigo Company today announced that it has received tentative approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets (repaglinide tablets).
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
As an embryo develops, different genes are turned on in different cells, to form muscles, neurons and other bodily parts. Inside each cell's nucleus, genetic sequences known as enhancers act like remote controls, switching genes on and off. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, can now see - and predict - exactly when each remote control is itself activated, in a real embryo.
› Verified 2 days ago
Dr. David Marc Wild, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 954 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-2300 Fax: 201-833-7600 | |
Joseph Frascino, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-3258 Fax: 201-833-3260 | |
Dr. Hrach Ike Kasaryan, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Frank W Burr Blvd, #22, Second Floor, Teaneck, NJ 07666 Phone: 201-928-2300 Fax: 201-692-3263 | |
Judy Mei-chia Lin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1086 Teaneck Rd Ste 4c, Teaneck, NJ 07666 Phone: 201-837-9449 Fax: 201-578-1699 | |
Dr. Ralph E Marcus, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1415 Queen Anne Rd, Teaneck, NJ 07666 Phone: 201-837-7788 Fax: 201-837-2077 | |
Mrs. Sarwat W Umer, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Cedar Ln, Teaneck, NJ 07666 Phone: 201-836-4248 Fax: 201-836-5420 | |
Dr. Erina Khadka Kunwar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 185 Cedar Ln Ste U7, Teaneck, NJ 07666 Phone: 201-300-2768 |